Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews - New Zealand
doi 10.2147/oarrr.s17118
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Informa UK Limited

Related search

Rosuvastatin for Tocilizumab, an Interleukin-6 Receptor Antibody-Induced Dyslipidemia in a Diabetic Patient Complicated With Rheumatoid Arthritis

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2011English

Anti-Interleukin 6 Receptor Antibody Treatment in Rheumatic Disease

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Exacerbation of Chronic Active Epstein-Barr Virus Infection in a Patient With Rheumatoid Arthritis Receiving Humanised Anti-Interleukin-6 Receptor Monoclonal Antibody

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

Immunotherapy of Tocilizumab for Rheumatoid Arthritis

Journal of Clinical & Cellular Immunology
2013English

Efficacy of Epidural Administration of Anti-Interleukin-6 Receptor Antibody Onto Spinal Nerve for Treatment of Sciatica

Global Spine Journal
OrthopedicsSurgeryNeurologySports Medicine
2012English

A Humanized Antibody That Binds to the Interleukin 2 Receptor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Anti-Interleukin-6 Receptor Antibody Therapy —From Bedside to Bench—

Japanese Journal of Clinical Immunology
2006English

Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis

Medical Council
2019English

Sarilumab: A New IL-6 Receptor Blocker for Rheumatoid Arthritis

Prescriber
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy